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Abstract
This study investigated the influence of age, body composition, physical fitness, training volume and intensity, and 
underlying systemic inflammation on exercise-induced inflammation and innate immune function in a heterogeneous 
group of cyclists. Subjects included 31 male cyclists (mean – standard deviation, age 38.8 – 10.6 years, body fat 17.8% – 
5.6%, VO2max 55.8 – 8.4 mL kg - 1 min - 1) who cycled for 1.75 h at 60% wattsmax followed by a 10-km time trial (18.3 
– 0.3 min). Blood samples were collected pre-, post-, and 1-h-postexercise, and analyzed for WBCs, 9 cytokines 
[interleukin (IL)-6, tumor necrosis factor-alpha, granulocyte-macrophage colony-stimulating factor, interferon-g, IL-1b, 
IL-2, IL-8, IL-10, and IL-12p70], and granulocyte and monocyte phagocytosis (GR-PHAG and MO-PHAG) and 
oxidative burst activity (GR-OBA and MO-OBA). Exercise- induced changes varied widely, with significant increases 
measured for 8 of 9 cytokines, GR-PHAG (mean change 99%) (95% confidence limits, 69%, 128%) and MO-PHAG 
(43%) (28%, 58%), and WBC (160%) (133%,187%), and decreases for GR-OBA (- 30%) (- 43%, - 16%) and MO-OBA (- 
23%) (- 36%, - 10%). Correlation and stepwise regression analysis revealed that changes in these variables were not 
related to age, body fat percentage, VO2max, training volume, or pre-exercise C-reactive protein. Performance 
measures, specifically the average heart rate and rating of perceived exertion, were correlated with changes in several 
variables, including IL-8 (r = 0.68 and 0.67, respectively, P < 0.001) and IL-6 (r = 0.51, P = 0.004, and r = 0.46, P = 0.011, 
respectively). In summary, variance in exercise-induced inflammation and innate immunity in male cyclists in response 
to 2 h of endurance exercise is best explained by exercise intensity.
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This study investigated the influence of age, body composition, physical fitness, training volume and intensity, 
and underlying systemic inflammation on exercise-induced inflammation and innate immune function in a 
heterogeneous group of cyclists. Subjects included 31 male cyclists (mean – standard deviation, age 38.8 – 10.6 
years, body fat 17.8% – 5.6%, VO2max 55.8 – 8.4 mL kg 
- 1 min - 1) who cycled for 1.75 h at 60% wattsmax followed 
by a 10-km time trial (18.3 – 0.3 min). Blood samples were collected pre-, post-, and 1-h-postexercise, and 
analyzed for WBCs, 9 cytokines [interleukin (IL)-6, tumor necrosis factor-alpha, granulocyte-macrophage 
colony-stimulating factor, interferon-g, IL-1b, IL-2, IL-8, IL-10, and IL-12p70], and granulocyte and monocyte 
phagocytosis (GR-PHAG and MO-PHAG) and oxidative burst activity (GR-OBA and MO-OBA). Exercise- 
induced changes varied widely, with significant increases measured for 8 of 9 cytokines, GR-PHAG (mean 
change 99%) (95% confidence limits, 69%, 128%) and MO-PHAG (43%) (28%, 58%), and WBC (160%) (133%, 
187%), and decreases for GR-OBA (- 30%) (- 43%, - 16%) and MO-OBA (- 23%) (- 36%, - 10%). Correlation 
and stepwise regression analysis revealed that changes in these variables were not related to age, body fat 
percentage, VO2max, training volume, or pre-exercise C-reactive protein. Performance measures, specifically the 
average heart rate and rating of perceived exertion, were correlated with changes in several variables, including 
IL-8 (r = 0.68 and 0.67, respectively, P < 0.001) and IL-6 (r = 0.51, P = 0.004, and r = 0.46, P = 0.011, respectively). In 
summary, variance in exercise-induced inflammation and innate immunity in male cyclists in response to 2 h of 
endurance exercise is best explained by exercise intensity. 
Introduction 
rolonged   and   intensive   exercise   can   cause   acute, 
transient  physiologic  stress,  elevations  in  stress  hor- 
mones, inflammation, oxidative stress, immune dysfunction, 
and disturbances in host pathogen defense (Nieman 1997, 
2000). Heavy exercise workloads are associated with eleva- 
tions in a variety of cytokines, including interleukin (IL)-6, 
IL-10, IL-8, IL-1ra, granulocyte colony-stimulating factor (G- 
CSF), monocyte chemoattractant protein 1, macrophage in- 
flammatory  protein  1  beta,  tumor  necrosis  factor-alpha 
(TNF-a), and macrophage migration inhibitory factor (Nie- 
man and others 2001; Nieman 2009). Cells from the innate 
immune system are particularly affected, with a transient 
postexercise increase in granulocyte phagocytosis, and de- 
creases in granulocyte oxidative burst activity and natural 
killer cell lytic activity (Nieman and others 1998). 
Blood  levels  of  inflammation-related  biomarkers  vary 
widely in individuals after intensive and prolonged exercise. 
For example, change in plasma IL-6, IL-8, and IL-10 levels 
varied widely [coefficient of variations (CV) of 1.23, 1.12, and 
1.20, respectively] in athletes competing in the 42.2 km 
Charlotte Marathon Race and the 160-km Western States 
Endurance Run (Nieman and others 2001; Nieman 2009). 
Predictors of this variance in post-exercise inflammation 
have not yet been determined. In the community, chronic 
or systemic inflammation is strongly related to age, body 
mass index, body composition, exercise frequency, and 
physical fitness status (Beavers and others 2010). 
Individuals engaging in endurance exercise vary widely in 
age, body composition, training workloads, and fitness 
levels, and whether or not variance in post-exercise 
inflammation and innate immune function is related to 
these demographic, training, and fitness factors has not yet 
been investigated. Additionally, although unstudied, 
variance in pre-exercise inflammation measures may 
predict the extent of exercise-induced inflammation. In 
other words, an individual with high baseline C-reactive 
protein (CRP) may experience an exaggerated 
 
 
inflammatory response to heavy exertion compared to those 
with low CRP. 
The purpose of this study was to investigate the influence 
of age, body composition, physical fitness, training habits, 
systemic inflammation, and metabolic demands on exercise- 
induced inflammation and innate immune function in a 
heterogeneous group of trained cyclists. We hypothesized 
that each of these factors would have a significant influence 
on the degree of inflammation experienced by cyclists 
following an intensive and prolonged bout of cycling. 
 
Materials and Methods 
Subjects 
Thirty-one male cyclists who trained for and competed in 
road or mountain bike races were recruited from the Char- 
lotte, NC, area via mass advertisement. Inclusion criteria 
included a capability of cycling 75 km in a laboratory setting, 
and a willingness to stay weight stable and avoid the use of 
large-dose vitamin/mineral supplements (more than 100% of 
recommended dietary allowances), herbs, and medications 
known to affect inflammation and immune function for 1 
month before the laboratory cycling session. Written in- 
formed consent was obtained from each subject, and the 
experimental procedures were approved by the institutional 
review board of Appalachian State University. 
 
Research design 
Before the study, subjects came to the Human 
Performance Laboratory for orientation and baseline 
testing. Demographic and training histories were acquired 
with questionnaires. Maximal power, oxygen consumption, 
ventilation, and heart rate were measured during a graded 
exercise test (25 watt increase every 2 min, starting at 150 
watts) with the Cosmed Quark CPET metabolic cart 
(Rome, Italy) and the Lode cycle ergometer (Lode 
Excaliber Sport, Lode B.V., Groningen, Netherlands). Body 
composition was measured with the Bod Pod body 
composition analyzer (Life Measurement, Concord, CA). 
Subjects were instructed to stay weight stable and avoid 
all medications and supplements known to influence 
inflammation and immune function for 1 month after 
baseline testing. 
One month after baseline testing, subjects returned to the 
Human Performance Laboratory at 2:45 p.m. for the cycling 
test session. The last meal was at 12:00 noon, and consisted of 
a standardized liquid meal (Boost Plus; Mead Johnson 
Nutritionals, Evansville, IN) at an energy level of 10 
kcal$kg- 1 
(41.9 kJ$kg- 1) body mass. Subjects provided blood samples, 
and then cycled from approximately 3:00 to 5:00 p.m., with 
additional blood samples collected immediately postexercise, 
and then again 1-h post-exercise. 
Subjects first cycled for 1.75 h using their own bicycle on 
CompuTrainer Pro Model 8001 trainers (RacerMate, Seattle, 
WA) with the exercise load set at 60% wattsmax, and heart 
rate and rating of perceived exertion (RPE) recorded every 
30 min and workload monitored using the CompuTrainer 
MultiRider software system (version 3.0; RacerMate, Seattle, 
WA). Immediately following, subjects engaged in a 10-km 
time trial, cycling as fast as possible while workload, heart 
rate, and RPE were recorded every 5 min. During the cycling 
bout, subjects drank water ad libitum, and no other beverage 
or food were consumed. RPE was determined using the Borg 
15-point rating (6–20) of perceived exertion scale (Utter and 
others 2009). 
During orientation, a dietitian instructed the subjects to 
follow a diet moderate in carbohydrate (using a food list) 
during the 3-day period before the cycling test session. 
Subjects recorded food intake in a 3-day food record before 
each of the test sessions, with the dietary record analyzed 
using a computerized dietary assessment program for 
energy and macronutrient content (Food Processor; ESHA 
Research, Salem, OR). 
 
Complete blood count, leukocyte subset counts, 
CRP, and creatine phosphokinase 
Routine complete blood counts were performed by our 
clinical hematology laboratory using a Coulter Ac.TTM 5Diff 
Hematology Analyzer (Beckman Coulter, Inc., Miami, FL) and 
provided leukocyte subset counts, and hemoglobin and 
hematocrit for the determination of plasma volume change 
using the method of Dill and Costill (1974). Creatine 
phosphokinase (CPK) and high-sensitivity CRP were 
measured using an LX-20 clinical analyzer (Beckman Coulter 
Electronics, Brea, CA). 
 
Granulocyte and monocyte phagocytosis 
and oxidative burst activity 
Granulocyte and monocyte phagocytosis and oxidative 
burst activity were measured as originally described by 
Szejda and others (1984), and adapted by our research group 
(Nieman and others 1998). Phagocytosis was measured 
through the uptake of fluorescein isothiocyanate (FITC)- 
labeled bacteria. Oxidative burst was measured through the 
oxidation of non-fluorescent-hydro-ethidine (HE) to 
fluorescent ethidium bromide in cells stimulated with 
unlabeled bacteria, and provides a quantitative assay of 
H2O2-dependent oxidative product formation generated by 
the cell’s oxidative metabolic burst (Szejda and others 
1984). Unlabeled and FITC-labeled bacteria 
(Staphylococcus aureus; Molecular Probes, Eugene, OR) 
were suspended in phosphate-buffered saline (PBS) to 
working concentrations of 133,333 particles/ 
mL. For each sample, 100 mL of blood were dispensed into 2 
polypropylene tubes. To 1 tube, 10 mL of HE working solution 
(10 mg HE/mL; Molecular Probes) was added and the tubes 
incubated at 37°C for 15 min, and then cooled at 4°C for 
12 min. Using a bacteria to phagocyte (neutrophils and 
monocytes) ratio of 8:1, unlabeled bacteria were added to the 
HE-loaded tubes and FITC-labeled bacteria were added to the 
second tube in the set. Both tubes were incubated at 37°C for 
20 min and placed in an ice water bath, and 100 mL of quench 
solution was added to allow suppression of surface-bound 
FITC bacteria fluorescence. Cells were washed twice with cold 
PBS and re-suspended in 50 mL cold fetal bovine serum. 
Samples were processed on a Q-Prep™ Workstation 
(Beckman Coulter, Inc.) and analysis was performed 
within 18 h of blood collection using a Beckman Coulter 
FC-500 flow cytometer. After gating on the granulocyte 
and monocyte populations using forward scatter and side 
scatter, the mean fluorescence intensity (MFI; x-mean) 
and percent positive cells for FITC (FL1) and oxidized HE 
(FL2) were determined. 
 
Plasma cytokines 
Total plasma concentrations of 9 inflammatory cytokines 
[IL-6,  TNF-a,  granulocyte-macrophage  colony-stimulating 
 
 
factor (GM-CSF), interferon gamma (IFN-g), IL-1b, IL-2, IL-8, 
IL-10, and IL-12p70] were determined using an electro- 
chemiluminescence-based solid-phase sandwich immunoas- 
say ( Meso Scale Discovery, Gaithersburg, MD). All samples 
and provided standards were analyzed in duplicate, and the 
Table 2.   Plasma Cytokine Measures Pre-exercise, 
Immediately Postexercise (2.1 h Cycling), 
and 1-h Postexercise in Cyclists (N = 31) 
(Mean – Standard  Deviation) 
 
 
Variable Pre-Exercise  Postexercise  1-h Postexercise 
intra-assay CV ranged from 1.7% to 7.5%, and the inter-assay        
CV 2.4%–9.6%, for all cytokines measured. The minimum 
detectable  concentration  of  IL-6  was  0.27 pg/mL,  TNF-a 
0.50 pg/mL, GM-CSF 0.20 pg/mL, IFN-g 0.53 pg/mL, IL-1b 
0.36 pg/mL,   IL-2   0.35 pg/mL,   IL-8   0.09 pg/mL,   IL-10 
0.21 pg/mL, and IL-12p70 1.4 pg/mL. Pre- and post-
exercise samples for the cytokines were analyzed on the 
same assay plate to decrease inter-kit assay variability. 
 
Statistical analysis 
Data are expressed as mean – standard deviation (SD) and 
were analyzed across time within each variable using paired 
t-tests contrasting pre-exercise levels with immediate post- 
exercise and 1-h post-exercise levels. Variance in pre-to- 
post-exercise was expressed as CV by dividing the SD 
of change by the mean change. Significance was set after 
Bonferroni adjustment at P £ 0.025. Pearson correlation 
coefficients were calculated between variables listed in Table 
1 and the change from pre-exercise to immediately post-
exercise for variables in Table 2. After determining that the 
average RPE and percent heart rate attained during the 
entire 2.1-h cycling bout were related to change in several 
inflammation measures, stepwise regression was used to 
test this relationship with age, percent body fat, VO2max, 
and CRP (baseline inflammation) listed as potential 
predictive variables for the stepwise regression model. 
 
Results 
Subject characteristics and performance measures 
Subject characteristics (N = 31) and performance measures 
for the 2.1-h cycling bout (1.75-h pre-load and 10-km time 
trial  combined)  are  summarized  in  Table  1.  The  cyclists 
 
Table 1.   Subject Characteristics and Cycling 
Performance Measures During the 2.1-h 
Cycling Bout (N = 31) 
 
 
Variable, subject characteristics Mean – SD 
 
 
Age (years) 38.8 – 10.6 
Height (m) 1.79 – 0.11 
Weight (kg) 79.0 – 10.0 
Body fat (%) 17.8 – 5.6 
Maximal power (watts) 360 – 45 
IL-1b (pg/mL)           0.33 – 0.33   0.42 – 0.33*      0.44 – 0.33*    
*P < 0.025 relative to pre-exercise. 
TNF-a, tumor necrosis factor-alpha; IL, interleukin; IFN-g, 
interferon-g; GM-CSF, granulocyte-macrophage colony-stimulating 
factor. 
 
 
ranged widely in age, body composition, and 
cardiorespiratory fitness levels. Subjects had been engaged 
in training and racing for 8.1 – 6.7 years (mean – SD), 
averaged 267 – 109 km/week in training, and were 
registered in cycling race categories ranging from the 
professional level down to class 
5. During the 1.75-h cycling bout and ending 10-km time trial 
(18.3 – 1.7 min), subjects cycled at 60% and 74% – 12% of 
wattsmax, respectively, for a 2.1-h average of 62% – 1% 
wattsmax. This workload resulted in a heart rate response of 
81% – 6% maximal heart rate (%HRmax), but this ranged 
widely from 68% to 93%. The RPE (6–20 scale) rose from 
12.1 – 1.1 at a power output of 216 – 27 watts during the first 
30 min of cycling to 19.0 – 1.1 at the end of the 10-km time 
trial and a power output of 355 – 115 watts. The average RPE 
for the entire 2.1-h cycling bout ranged from 11.5 to 15.4. 
Heart rate and average RPE were positively correlated as 
exercise intensity measures (r = 0.59, P = 0.001 for average 
heart rate, and r = 0.50, P = 0.005 for %HRmax). Weight loss 
averaged 1.2 – 0.6 kg immediately after the cycling bout, with 
a plasma volume decrease of 2.1% – 0.1%. CPK increased 
slightly from 200 – 121 to 228 – 145 immediately postexercise 
(P < 0.001). Three-day food records before the exercise trial 
showed that energy intake was 2,639 – 640 kcal/day (11.1 – 2.8 
MJ/day) with carbohydrate representing 55.6% – 8.4%, 
protein 17.3% – 3.9%, and fat 27.1% – 7.2% of total energy. 
 
Cytokine and innate immune measures 
Tables 2 and 3 summarize exercise-induced increases in 
Maximal oxygen consumption, 
VO2max (mL kg 
- 1 min- 1) 
Maximal ventilation, VEmax 
(L.min- 1) 
Maximal heart rate, HRmax 
(beats.min - 1) 
55.8 – 8.4 
159 – 20 
180 – 13 
plasma levels for 8 of 9 cytokines, total blood leukocytes, and 
granulocyte and monocyte phagocytosis, and decreases 
measured 1-h post-exercise for granulocyte and 
monocyte oxidative burst activity. The changes 
immediately after exercise for these variables varied widely. 
For example, CVs for pre-to-post-exercise changes in 
plasma IL-6, IL-8, and IL-10 were 0.77, 0.58, and 1.51, 
respectively. CVs for granulocyte 
Performance measures, 2.1-h cycling  Mean – SD  % Maximal 
 
 
Power output (watts) 222 – 30 61.6% – 1.1% 
Heart rate (beats.min- 1)  146 – 18 81.2% – 6.1% 
Rating of perceived exertion 13.3 – 1.1 
10-km time trial (min) 18.3 – 1.7 
 
 
SD, standard deviation. 
phagocytosis and total blood leukocytes were 0.81 and 0.47, 
respectively. 
 
Correlation and regression statistics 
Correlation coefficients were analyzed for age, VO2max, 
and training volume (Table 1), and the pre-to-post-exercise 
TNF-a (pg/mL) 6.07 – 1.4 7.98 – 1.95* 7.63 – 1.78* 
IL-6 (pg/mL) 1.57 – 1.7 11.4 – 7.3* 7.84 – 4.23* 
IL-2 (pg/mL) 1.11 – 1.1 1.59 – 1.22* 1.22 – 0.72 
IL-12-p70 (pg/mL) 3.38 – 5.5 3.74 – 6.01 3.24 – 5.57 
IL-8 (pg/mL) 3.31 – 1.2 9.16 – 3.62* 8.93 – 4.01* 
IL-10 (pg/mL) 2.94 – 1.7 12.2 – 13.9* 16.3 – 14.5* 
GM-CSF (pg/mL) 1.34 – 1.4 1.49 – 0.84* 1.47 – 0.67 
IFN-g (pg/mL) 1.74 – 1.4 1.98 – 1.45* 1.84 – 1.17 
 
 
 
Table 3.   Innate Immune and Leukocyte Subset Count Measures Pre-Exercise, Immediately 
Post-exercise (2.1 h Cycling), and 1-h Post-exercise in Cyclists (N = 31) (Mean – Standard 
Deviation) 
 
Variable Pre-Exercise Post-exercise 1-h Post-exercise 
Granulocyte phagocytosis (MFI) 144 – 74 243 – 101* 224 – 82* 
Monocyte phagocytosis (MFI) 88.4 – 41.8 131 – 55* 154 – 59* 
Granulocyte oxidative burst activity ( MFI) 18.2 – 1.3 18.6 – 1.0 11.7 – 5.0* 
Monocyte oxidative burst activity (MFI) 
Total blood leukocyte count (109$L - 1) 
Blood neutrophil count (109$L- 1) 
Blood lymphocyte count (109$L- 1) 
Blood monocyte count (109$L- 1) 
11.4 – 0.6 
6.28 – 0.31 
3.66 – 0.24 
1.85 – 0.09 
0.49 – 0.03 
13.1 – 0.6* 
15.9 – 1.0* 
11.4 – 0.8* 
3.14 – 0.18* 
0.99 – 0.08* 
8.53 – 3.90* 
13.6 – 4.5* 
11.1 – 3.9* 
1.44 – 0.45* 
0.70 – 0.28* 
*P < 0.025 relative to pre-exercise.    
MFI, mean fluorescence intensity.    
 
change in variables listed in Table 2, and none were found to 
be significant. 
Pre-exercise measures of chronic inflammation (CRP, 
plasma cytokines, and the total blood leukocyte count) 
varied widely. For example, CVs for serum CRP, plasma 
IL-6, and total blood leukocyte counts were 0.92, 0.75, and 
0.28, respectively. Pre-exercise serum CRP was positively 
correlated with  percent  body  fat  in  these  cyclists  (r = 
0.66, P < 0.001). However, pre-exercise measures of  chronic 
inflammation were not significantly correlated with 
exercise- induced changes in Table 2 variables. 
Performance measures, specifically the average RPE and 
%HRmax attained during the 2.1-h cycling bout, were 
significantly correlated with change in several variables 
listed in Table 2. Figure 1A and B shows the significant, 
positive relationship between the average %HRmax and RPE 
maintained during the cycling bout with the pre-to-post-
exercise change in plasma IL-8 (r = 0.68 and 0.67, 
respectively, both P < 0.001).  Similar significant  
correlations  were  found  for 
%HRmax and change in plasma IL-6 (r = 0.51, P = 0.004), TNF-a 
(r = 0.51,   P = 0.004),   granulocyte    phagocytosis    (r = 0.45, 
P = 0.013), monocyte phagocytosis (r = 0.38, P = 0.038), and 
the total blood leukocyte count (r = 0.38, P = 0.040). Exercise 
RPE was  also  related  to  change  in  plasma  IL-6  (r = 0.46, 
P = 0.011) and TNF-a (r = 0.40, P = 0.028). Stepwise regression 
failed to demonstrate that age, percent body fat, VO2max, and 
CRP (baseline inflammation) were significant predictor 
variables, and, consequently, none of these factors entered 
into the regression equation. 
 
Discussion 
The 1.75-h cycling bout at 60% wattsmax combined with a 
10-km cycling time trial induced significant inflammation in 
this heterogeneous group of trained cyclists, but the magni- 
tude varied widely between subjects. We had hypothesized 
that unique subject characteristics such as age, body com- 
position, cardiorespiratory fitness level, training volume, and 
systemic inflammation would predict the extent of post-
exercise inflammation, but correlation and stepwise 
regression statistical analysis was non-supportive. In 
contrast, exercise- induced changes in plasma cytokine 
levels and granulocyte and monocyte phagocytosis were 
related to metabolic de- mand measures including the 
average RPE and %HRmax maintained during the 2.1-h 
cycling bout. Perceived exertion reflects the intensity of 
effort, strain, discomfort, and fatigue experienced by the 
subject during exercise, and is mediated 
by central and peripheral physiologic indicators (Utter and 
others 2009). Heart rate and RPE measures during the 2.1-h 
cycling bout were positively correlated with each other and 
several inflammatory measures in this study. 
The magnitude of increase in plasma levels of 8  of 9 
cytokines, total blood leukocytes, and granulocyte and 
monocyte phagocytosis, and decrease in granulocyte and 
 
 
 
 
FIG. 1. (A, B) The average heart rate (%HRmax) and rating 
of perceived exertion maintained during the 2.1-h cycling 
bout were positively correlated with the pre-to-postexercise 
change in plasma IL-8 (r = 0.68 and 0.67, respectively, both 
P < 0.001). IL-8, interleukin-8. 
 
 
monocyte oxidative burst activity measured in the cyclists 
participating in this study, is similar to what we have re- 
ported for runners and cyclists exercising for 2–3 h in other 
laboratory studies but below what endurance runners 
experience in marathon and ultramarathon race events 
(Nieman and others 2001, 2008, 2009; Nieman 2009; Utter 
and others 2009). To induce the largest inflammatory re- 
sponse, cyclists were restricted to water only during the 
exercise bout because carbohydrate intake attenuates the 
rise in cytokines and phagocytosis (Nieman 1997; Nieman 
and others 1998, 2001). The combined physiologic stress of 
prolonged and  intensive exercise under carbohydrate- 
restricted conditions is associated with a large but variable 
increase in plasma cytokine levels. Low-intensity exercise, 
such as brisk walking, results in little or no increase in 
plasma cytokine levels (Nieman and others 2005b). The 
data from this study indicate that the largest change in 
plasma cytokine levels, and granulocyte and monocyte 
phagocytosis, occurred in athletes exercising at the highest 
intensities during the 2.1-h cycling bout. This relationship 
between exercise intensity and exercise-induced 
inflammation was measured in a group of cyclists varying 
widely in age, body composition, cardiorespiratory fitness 
level, training volume, and pre-exercise CRP, and none of 
these factors confounded this linkage. 
Exercise-induced increases in cytokines are produced by 
multiple cell types both within and outside the immune 
system (Keller and others 2001; Frydelund-Larsen and others 
2007; Nielsen and Pedersen 2008). Several laboratory studies 
indicate that IL-6, IL-8, IL-1b, and TNF-a mRNA content is 
increased within postexercise skeletal muscle biopsy 
samples, with the greatest fold increases measured for IL-6 
and IL-8 mRNA (Nieman and others 2003). Laboratory 
studies also indicate that blood leukocytes may produce IL-
8, IL-10, and IL-1ra during sustained exercise (Nieman 
and others 2006a). Primary signaling mechanisms for 
cytokine gene expression during exercise are poorly 
understood, but data suggest that nitric oxide production, 
leakage of endotoxins (lipopolysaccharide) from the 
intestines, elevation in cate- cholamines and cortisol, high 
core body temperature, muscle damage, oxidative stress, 
and glycogen deficiency are in- volved (Suzuki and 
others 1999; Nieman and others 2006b; Steensberg and 
others 2007). Each of these proposed mech- anisms has 
some linkage with exercise intensity. We have previously 
associated endotoxemia from ibuprofen use and muscle 
damage (ie, elevated serum CPK) with elevated se- rum 
CRP and plasma cytokines in ultramarathoners com- 
peting in the 160-km Western States Endurance Run 
(Nieman and others 2005a, 2006b). In the current study, cy- 
clists did not use ibuprofen for a month before the cycling 
test session, and muscle damage was low as supported by 
the small increase in serum CPK. Others have shown that 
exercise-induced muscle glycogen depletion increases skele- 
tal muscle IL-6 production, and this is consistent with the 
preference for muscle glycogen as a fuel during high inten- 
sity exercise (Steensberg and others 2001; Keller and others 
2001, 2005). 
In conclusion, exercise intensity (both %HRmax and RPE) 
was the best predictor of the acute inflammatory response to 
2.1 h exercise in a heterogeneous group of cyclists. Contrary 
to expectations, age, body composition, fitness level, training 
volume, and pre-exercise CRP were unrelated to the 
magnitude of exercise-induced changes in inflammatory 
mea- 
sures. Thus, the degree of physiologic stress experienced by 
the cyclist during prolonged exercise is an important factor 
in predicting the acute inflammatory response. Data from 
larger groups are needed to confirm these findings and 
determine practical applications. For example, if high post-
exercise inflammation is linked to increased risk of upper 
respiratory tract infection or other negative health outcomes 
in certain types of individuals (eg, diminished metabolic 
control in individuals with type 2 diabetes), exercise intensity 
thresholds may help improve the benefit–risk ratio from 
long-term training. 
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